TFE3 and renal cell carcinoma: Among the 120 patients, 61.7% (74/120) were pathologically diagnosed with papillary RCC (pRCC), 25.8% (32/120) were diagnosed with TFE3-RCC, and 9.2% (11/120) remained undetermined in terms of pathological classification.